Related Experiment Video

Updated: Apr 20, 2026

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells
09:20

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells

Published on: July 6, 2021

2.9K

Targeting RAS-ERK signalling in cancer: promises and challenges

Ahmed A Samatar1, Poulikos I Poulikakos2

  • 1TheraMet Biosciences, 6 Jacob Drive, Princeton Junction, New Jersey 08550, USA.

Nature Reviews. Drug Discovery
|December 2, 2014
PubMed

Insights

Targeting the RAS-RAF-MEK-ERK pathway with RAF or MEK inhibitors improves outcomes in some cancers but resistance limits efficacy. Persistent ERK signaling drives resistance, necessitating novel therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • The RAS-RAF-MEK-ERK pathway is frequently hyperactivated in tumors due to KRAS, NRAS, and BRAF mutations.
  • RAF and MEK inhibitors have shown clinical benefit in metastatic melanoma and other cancers.

Purpose of the Study:

  • To investigate the mechanisms of resistance to RAF and MEK inhibitors.
  • To identify novel therapeutic strategies to overcome drug resistance in cancer treatment.

Main Methods:

  • Analysis of signaling pathway activity in resistant tumors.
  • Evaluation of novel drug combinations or therapeutic approaches.

Main Results:

  • Resistance to RAF and MEK inhibitors is often associated with sustained ERK signaling.
  • Persistent ERK signaling indicates a key mechanism of therapeutic failure.

Conclusions:

  • Developing innovative strategies is crucial to overcome resistance to RAF and MEK inhibitors.
  • Targeting the RAS-RAF-MEK-ERK pathway requires addressing resistance mechanisms for improved patient outcomes.

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.4K
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.6K

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.5K
The Ras Gene02:38

The Ras Gene

2.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K